HemaSphere
(Jun 2022)
P339: BOOSTING THE EFFICACY OF CD20-TARGETING IMMUNOTHERAPY IN B CELL ACUTE LYMPHOBLASTIC LEUKEMIA
- M. Poprzeczko,
- K. Domka,
- A. Pastorczak,
- K. Fidyt,
- L. Komorowski,
- M. Winiarska,
- A. Dabkowska,
- K. Siudakowska,
- A. Wojciechowska,
- E. Patkowska,
- M. Firczuk
Affiliations
- M. Poprzeczko
- 1 Laboratory of Immunology, Mossakowski Medical Research Institute Polish Academy of Sciences
- K. Domka
- 1 Laboratory of Immunology, Mossakowski Medical Research Institute Polish Academy of Sciences
- A. Pastorczak
- 3 Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz
- K. Fidyt
- 2 Department of Immunology, Medical University of Warsaw, Warsaw
- L. Komorowski
- 1 Laboratory of Immunology, Mossakowski Medical Research Institute Polish Academy of Sciences
- M. Winiarska
- 2 Department of Immunology, Medical University of Warsaw, Warsaw
- A. Dabkowska
- 2 Department of Immunology, Medical University of Warsaw, Warsaw
- K. Siudakowska
- 2 Department of Immunology, Medical University of Warsaw, Warsaw
- A. Wojciechowska
- 2 Department of Immunology, Medical University of Warsaw, Warsaw
- E. Patkowska
- 4 Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
- M. Firczuk
- 1 Laboratory of Immunology, Mossakowski Medical Research Institute Polish Academy of Sciences
- DOI
-
https://doi.org/10.1097/01.HS9.0000844244.84448.ad
- Journal volume & issue
-
Vol. 6
pp.
239
– 240
WeChat QR code